Article: MDECHEM'S MAXHEAL to Be Tested by The National Institutes of Health For Control of SARS.

Business Editors/Health/Medical Writers

HOUSTON--(BUSINESS WIRE)--Aug. 26, 2003

MDECHEM'S (Pink Sheets:MDKM) anti-viral, anti-bacterial product, MAXHEAL(C), in collaboration with Omega Pharmaceuticals, Birmingham, Ala., has been accepted for testing for control of Coronavirus-Severe Acute Respiratory Syndrome (SARS) under a program funded by The National Institutes of Health (NIH). While a testing schedule has not been announced, MDECHEM believes the testing will begin in the near future.

MDECHEM's affiliate, MED QUIMICA, SA., of San Jose, Costa Rica, has received, earlier this year, approval for the marketing of MAXHEAL in Costa Rica as an ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!